Tim Brunson DCH

Welcome to The International Hypnosis Research Institute Web site. Our intention is to support and promote the further worldwide integration of comprehensive evidence-based research and clinical hypnotherapy with mainstream mental health, medicine, and coaching. We do so by disseminating, supporting, and conducting research, providing professional level education, advocating increased level of practitioner competency, and supporting the viability and success of clinical practitioners. Although currently over 80% of our membership is comprised of mental health practitioners, we fully recognize the role, support, involvement, and needs of those in the medical and coaching fields. This site is not intended as a source of medical or psychological advice. Tim Brunson, PhD

Alfred A Barrios, Ph.D.



Alfred A. Barrios (B.S. Caltech 1955 in chemistry; Ph.D. UCLA 1969 in psychology) is Director of the Self-Programmed Control. He is the inventor of the Stress Control Biofeedback Card. In 1996, he was nominated for the Norman Cousins Award in Mind-Body Medicine and received the Cancer Federation Award in Psychoneuroimmunology. He is the author of Towards Greater Freedom & Happiness; The Habit Buster and The Stress Test. The latter, rose to number two on the Times best-seller list. His theory of hypnosis was recently published in Contemporary Hypnosis.

For more information visit: www.StressCards.com

Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease.



Hypnotically assisted treatments have been used to reduce stress, improve gastrointestinal motility, strengthen immune function, and potentially reduce inflammation. Such treatments may also help reduce disease flares and improve quality of life in inflammatory bowel diseases (IBD). The authors report the results of a case series of 8 white female patients with inactive IBD. All participants initiated and completed treatment, supporting the general acceptability of hypnotically assisted treatment among IBD patients. There was a significant improvement in IBD-quality of life scores for the group posttreatment, t(7) = -3.38, p = .01, with a mean improvement in quality of life of 29 points with significant changes in all 4 subscales. No negative effects of treatment were found. Int J Clin Exp Hypn. 2007 Oct;55(4):457-66. Keefer L, Keshavarzian A. Rush University Medical Center, Chicago, Illinois, USA.

© 2000 - 2025The International Hypnosis Research Institute, All Rights Reserved.

Contact